1. Home
  2. OHI vs NBIX Comparison

OHI vs NBIX Comparison

Compare OHI & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omega Healthcare Investors Inc.

OHI

Omega Healthcare Investors Inc.

SELL

Current Price

$45.66

Market Cap

14.0B

Sector

Real Estate

ML Signal

SELL

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

SELL

Current Price

$135.99

Market Cap

15.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OHI
NBIX
Founded
N/A
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0B
15.5B
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
OHI
NBIX
Price
$45.66
$135.99
Analyst Decision
Buy
Strong Buy
Analyst Count
20
29
Target Price
$51.44
★ $206.81
AVG Volume (30 Days)
★ 1.9M
1.3M
Earning Date
11-03-2026
11-02-2026
Dividend Yield
★ 5.97%
N/A
EPS Growth
25.16
★ 41.95
EPS
1.66
★ 3.30
Revenue
★ $1,190,099,000.00
$161,626,000.00
Revenue This Year
N/A
$36.39
Revenue Next Year
$6.48
$16.93
P/E Ratio
★ $27.42
$41.55
Revenue Growth
13.19
★ 977.51
52 Week Low
$39.26
$122.14
52 Week High
$52.39
$186.12

Technical Indicators

Market Signals
Indicator
OHI
NBIX
Relative Strength Index (RSI) 49.81 34.85
Support Level $45.17 $125.18
Resistance Level $46.90 $138.74
Average True Range (ATR) 0.81 3.55
MACD 0.09 -0.08
Stochastic Oscillator 66.96 26.05

Price Performance

Historical Comparison
OHI
NBIX

About OHI Omega Healthcare Investors Inc.

Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: